Commerce Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Commerce Advisors's BMY Position: Q2 2026 in Review
Commerce Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.29% in Q2 2026, buying an estimated $2.47K and bringing the position to 14,688 shares worth $846K. The position accounts for 0.46% of the portfolio, ranked #36.
Commerce Advisors first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $888K in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Commerce Advisors held 14,688 shares of Bristol-Myers Squibb worth $846K as of Q2 2026.
- Commerce Advisors bought 43 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.47K.
- Bristol-Myers Squibb made up 0.46% of Commerce Advisors's portfolio in Q2 2026, its #36 holding.
- Commerce Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Commerce Advisors's Bristol-Myers Squibb position peaked at $888K in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Commerce Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.